These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 21276754)
1. Management of uncommon chemotherapy-induced emergencies. Morgan C; Tillett T; Braybrooke J; Ajithkumar T Lancet Oncol; 2011 Aug; 12(8):806-14. PubMed ID: 21276754 [TBL] [Abstract][Full Text] [Related]
2. Toxicologic emergencies in the intensive care unit: management using reversal agents and antidotes. Patel SR Crit Care Nurs Q; 2013; 36(4):335-44. PubMed ID: 24002424 [TBL] [Abstract][Full Text] [Related]
3. Pediatric Hematologic and Oncologic Emergencies. Stephanos K; Dubbs SB Emerg Med Clin North Am; 2021 Aug; 39(3):555-571. PubMed ID: 34215402 [TBL] [Abstract][Full Text] [Related]
7. Steroid-Associated Side Effects: A Symptom Management Update on Multiple Myeloma Treatment . King T; Faiman B Clin J Oncol Nurs; 2017 Apr; 21(2):240-249. PubMed ID: 28315528 [TBL] [Abstract][Full Text] [Related]
8. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real. Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978 [TBL] [Abstract][Full Text] [Related]
9. Pets might reduce side-effects related to chemotherapy in patients with cancer. Aral H; Altundag K J BUON; 2021; 26(3):1173. PubMed ID: 34268992 [No Abstract] [Full Text] [Related]
15. Management of acute contrast media reactions: assessing preparedness of a tertiary care veterans affairs medical center. Favinger J; Bastawrous S; Bhargava P J Am Coll Radiol; 2013 Nov; 10(11):872-4. PubMed ID: 23433785 [No Abstract] [Full Text] [Related]
16. [Current guidelines for prevention and management of chemotherapy extravasation]. Bahyrycz J; Pityński K; Ludwin A; Ludwin I; Gawlik M Przegl Lek; 2012; 69(12):1283-6. PubMed ID: 23750440 [TBL] [Abstract][Full Text] [Related]
17. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. Cury-Martins J; Eris APM; Abdalla CMZ; Silva GB; Moura VPT; Sanches JA An Bras Dermatol; 2020; 95(2):221-237. PubMed ID: 32165025 [TBL] [Abstract][Full Text] [Related]
18. Acute reactions to chemotherapy agents. de Lemos ML J Oncol Pharm Pract; 2006 Sep; 12(3):127-9. PubMed ID: 17022867 [TBL] [Abstract][Full Text] [Related]
19. [Progress of the mechanism for chemotherapeutic drugs induced neurotoxicity and its clinical treatment research]. Zhang JZ; Zheng WH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):286-8. PubMed ID: 22574611 [No Abstract] [Full Text] [Related]
20. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Sauerland C; Engelking C; Wickham R; Corbi D Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]